There is no consistent evidence of increased thyroid cancer risk in humans to date
If you are at the 36 month mark of GLP-1 treatment and beginning to think about what comes next, the article on what months 3 to 6 on GLP-1 tend to look like offers useful context on that phase and the questions that often come up at that stage
The length of the study whether short-term or long-term also affects cumulative dosing and helps manage potential toxicity risks
Approximately 70% of newly diagnosed bladder cancers are non-muscle invasive (superficial), for which the standard of care treatment is Bacillus Calmette-Gurin (BCG) intravesical therapy
B12 injections are injected into the muscle and dispersed over time, therefore bypassing the digestive tract, so you get much higher absorption than you would orally
Though the panels decision is a green flag for the peptide industry, there remain a number of regulatory steps before the peptides it approved can be taken to market for legal human consumption